You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelofibrosis

Showing 1 - 25 of 577
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Ipoh, Perak, Malaysia
    Hospital Raja Permaisuri Bainun
Jul 18, 2022

Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

Recruiting
  • Myelofibrosis; Anemia
  • +5 more
  • Canton, Ohio
  • +1 more
Jun 10, 2022

Assess Real-World Patient-Reported Outcomes With Fedratinib for

Recruiting
  • Myelofibrosis
    • City, State, Austria
      Local Institution
    Dec 16, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    Ruxolitinib in Patients With Myelofibrosis

    Completed
    • Myelofibrosis
    • (no location specified)
    Jun 5, 2022

    Myelofibrosis Trial in France (Clonal architecture determination)

    Not yet recruiting
    • Myelofibrosis
    • Clonal architecture determination
    • Angers, France
    • +6 more
    Jan 24, 2023

    Myelofibrosis Trial in Jinan (Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Jinan, Shandong, China
      Qilu Hospital of Shandong University
    Jul 3, 2022

    Myelofibrosis Trial in Hong Kong (Bomedemstat)

    Recruiting
    • Myelofibrosis
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Saint Louis, Missouri
      Washington University School of Medicine
    May 6, 2022

    Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

    Active, not recruiting
    • Myelofibrosis
    • Long-term Follow-up
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    Myelofibrosis, Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) Trial in

    Completed
    • Myelofibrosis
    • +3 more
    • Ann Arbor, Michigan
    • +4 more
    Mar 28, 2022

    Myelofibrosis Trial in Gilbert, Houston (APG-1252, Ruxolitinib)

    Withdrawn
    • Myelofibrosis
    • Gilbert, Arizona
    • +1 more
    Jul 8, 2022

    Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)

    Recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Greifswald, Germany
    • +1 more
    Jun 15, 2022

    Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

    Not yet recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablet
    • (no location specified)
    Mar 3, 2022

    Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

    Not yet recruiting
    • Myelofibrosis
    • Pegylated interferon alpha2a
    • Salt Lake City, Utah
      Huntsman Cancer Institute at the University of Utah
    Sep 6, 2022

    Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Canton, Ohio
      Gabrail Cancer Center
    Aug 3, 2022

    Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

    Active, not recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Laboratory Biomarker Analysis
    • +2 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Jan 7, 2022

    A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

    Active, not recruiting
    • Primary Myelofibrosis
    • +2 more
    • Jakavi
    • Aachen, Germany
      Novartis Investigative Site
    Sep 6, 2021

    Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis

    Recruiting
    • Myelofibrosis
    • Hematopoietic Stem Cell Transplant
    • Minneapolis, Minnesota
      Center for International Blood and Marrow Transplant Research
    Mar 17, 2022

    Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

    Recruiting
    • Primary Myelofibrosis, Prefibrotic Stage
    • Myelofibrosis
    • Ropeginterferon alfa-2b
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Jul 25, 2021

    Myelofibrosis Trial in Worldwide (Ruxolitinib)

    Completed
    Has Results
    • Myelofibrosis
    • Winter Park, Florida
    • +17 more
    Jan 10, 2022

    Myelofibrosis Trial in Coral Gables, Tampa, New York (Imetelstat, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Coral Gables, Florida
    • +2 more
    Jul 12, 2022

    Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Rochester, Minnesota
      (unnamed)
    Aug 24, 2021

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Feb 10, 2022